Search Results

The Jeb E. Brooks School of Public Policy at Cornell University recently announced the launch of its new Biotech and Pharmaceutical Management Program aimed at preparing the next generation of leaders in the rapidly evolving biotechnology and pharmaceutical fields.

Applied DNA Sciences, Inc. and the Cornell University College of Veterinary Medicine announced the signing of a sponsored research agreement for a translational research study to accelerate the development and optimization of the Company’s LineaDNA™-lipid nano particle -based veterinary vaccine platform for veterinary diseases.

Dr. Robert A. Harrington, a cardiologist and the Arthur L. Bloomfield Professor of Medicine and chair of the Department of Medicine at Stanford University, has been named the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and provost for medical affairs of Cornell University.

Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.

Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company, today announced an in-license agreement with Cornell University to expedite development of the investigational gene therapy candidate LX2006 for the treatment of Friedreich ataxia (FA) cardiomyopathy.

The Feinstein Institutes for Medical Research has selected Michelle Monje, MD, PhD, from Stanford University, to receive the 11th annual Ross Prize in Molecular Medicine for her outstanding contributions to research relating to the neuroscience of cancer and its implications for therapy.

Pfizer is proud to announce that it is supporting a McMaster University-led study, through the Ontario Clinical Oncology Group, that aims to improve care for Canadians living with multiple myeloma.

The University of Cincinnati Cancer Center inaugurated its state-of-the-art Blood Cancer Healing Center, revolutionizing blood cancer care in the United States.

University Cancer & Blood Center, a leading oncology and hematology practice for Northeast Georgia, and University Health Alliance, a multi-disciplinary practice focusing on prevention and coordinated care, announce the opening of their High-Risk GI Clinic.

AMRA Medical in collaboration with Linköping University, is pleased to announce the completion of baseline enrollment for the innovative ACCESS-ESLD study.